Dr. Yotam Levin has been the CEO of NanoPass Technologies Ltd. since 2002. He is in charge of the Company's strategy, business development, and all clinical activities. Under his supervision the company successfully licensed its product with the FDA and the European authorities, and conducted pioneering intradermal vaccination studies. Prior to becoming CEO at NanoPass, Dr Levin was head of the biomedical consulting practice at Global Business Solutions, an Israeli strategic consulting firm. Dr Levin holds an MD degree and an MBA (finance), both from Tel Aviv University, Israel. Dr Levin authored several key publications in leading journals such as the Lancet Infectious Diseases, Vaccine, Journal of Infectious diseases (JID) and Human Vaccines & Immunotherapeutics (HV&I(, and participated in authoring over a two-dozen patent applications. He serves as a frequent reviewer for Vaccine, JID and HV&I, and was a Guest Editor for Vaccine’s Skin Vaccination Summit 2015. In his spare time, he runs marathons, teaches biomedical entrepreneurship and volunteers with a disabled children NPO.
Dr. Efrat Kochba has joined NanoPass Technologies Ltd. in 2012 as medical director and is in charge of managing the clinical activities of the company, as well as business development and marketing activities. Dr. Kochba brings a wide experience in the field of drug delivery working for TransPharma Medical Ltd., a company that focused on transdermal drug delivery. Efrat holds an MD degree from the Hebrew university in Jerusalem and practiced ENT medicine for six years prior to joining Roche pharmaceuticals as a medical and clinical trials manager.
Gal Admati joined NanoPass Technologies Ltd. In 2012. Gal is NanoPass' COO and oversees daily activities including marketing and sales, production, operations, R&D, quality, regulation and administration. Gal joined NanoPass as R&D director and was in charge of the company’s research and development activities as well as the company’s engineering activities and device manufacturing processes. Gal has experience in management, medical device research and development, machining, design, micro mechanics and mechanical automation. Gal has a B.Sc. in biomedical engineering and an MBA with a specialization in Strategy from Tel Aviv University
Tamir Shefer joined NanoPass Technologies Ltd. In March 2017 as QA director and is in charge of the quality processes of the organization. Tamir brings more than 20 years of experience in quality assurance and regulatory affairs compiling regulatory files to regulatory authorities and establishing and maintaining quality systems mainly in medical devices industry, for active and non-active devices including critical care devices, diagnostic devices, and active implants. Tamir worked for Philips Healthcare, Cheetah Medical, BioControl Medical, Direx, Given Imaging (acquired by Medtronic) and Biometrix Medical and holds a B.Sc. in biology from Technion Israel Institute of technology
Yoav Hamisha joined NanoPass Technologies Ltd. In July 2018 as Director of Engineering and Product Development and is in charge of all company’s engineering and product development activities. Yoav has over 15 years of experience in mechanical engineering, Engineering management, mainly of Semiconductors industry, printing industry & medical devices industry, in the fields of non-invasive fat reduction. Yoav has a B.Sc. in Mechanical engineering from Ben Gurion University and worked for Nur Macroprinters Ltd, HP Scitex Ltd., Ultrashape Ltd. and Nova measuring instruments Ltd.